Search results

Accommodation Information

Technical information on the Far Infrared beamline at the Australian Synchrotron.

After careful selection, three Australian science teachers are set to fly to Geneva today after winning positions on the International High School Teacher Programme at CERN.

Biochemical and structural studies to elucidate protein interactions of the new compounds and target molecules included X-ray diffraction at the Australian Synchrotron.

Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.

X-ray absorption spectroscopy (XAS) is a versatile tool for chemistry, biology, and materials science. By probing how x rays are absorbed from core electrons of atoms in a sample, the technique can reveal the local structure around selected atoms.

Although Australia does not use nuclear energy for power needs, it does have the nuclear capabilities, knowledge, and expertise provided by ANSTO to ensure the national interest in nuclear matters is protected and advanced.

Dr Emily Finch, Microscopy Group Manager at the Australian Synchrotron, has been selected among fourteen up-and-coming leaders of Australian science to participate in Australian Academy of Technological Sciences and Engineering (ATSE) Emerging Leaders Network 2026 which supports high-potential rising professionals in STEM.

Billions of tonnes of iron ore tailings are generated each year from the mining industry. Converting these toxic tailings into soil-like materials which can develop and sustain plant and microbial communities is critical for mine site remediation and improved environmental outcomes.

The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.

ANSTO is proud to announce that a license has been issued by the Therapeutic Goods Administration to produce Lutetium-177 (Lu-177) for use in clinical trials.

ANSTO’s Centre for Accelerator Science has been selected as a partner facility in RADNEXT 2030, a major European initiative that provides researchers and industry with access to radiation testing infrastructure for electronics.

ANSTO is participating in a major project to learn more about an important component of the atmosphere, the hydroxyl radical.

Creating a global energy system that is both environmentally and economically sustainable is unquestionably one of the largest challenges facing the scientific and engineering communities.

Biodeuteration involves the growth of microorganisms in a heavy water (deuterium oxide) culture medium supplemented with either a deuterated or hydrogenated carbon substrate, depending on the level of deuteration required. The biomass is harvested and the deuterated molecule (e.g. protein) is purified and characterised.